poisar

Stocks · News reference

GSK Q2 Adj. EPS $1.35 Beats $1.27 Estimate, Sales $11.280B Beat $10.790B Estimate

BenzingaJul 28, 2026, 11:19 AMBenzinga Newsdesk

GSK (NYSE:GSK) reported quarterly earnings of $1.35 per share which beat the analyst consensus estimate of $1.27 by 6.3 percent. This is a 8.87 percent increase over earnings of $1.24 per share from the same period last

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 28, 2026, 11:19 AM
Checked
Jul 28, 2026, 11:19 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading